No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / administration & dosage*
-
Cyclophosphamide / adverse effects
-
Disease Progression
-
Drug Administration Schedule
-
Female
-
Humans
-
Immunoblastic Lymphadenopathy / drug therapy*
-
Immunoblastic Lymphadenopathy / mortality
-
Immunoblastic Lymphadenopathy / pathology
-
Lymphoma, T-Cell / drug therapy*
-
Lymphoma, T-Cell / mortality
-
Lymphoma, T-Cell / pathology
-
Male
-
Middle Aged
-
Survival Analysis
-
Thalidomide / administration & dosage*
-
Thalidomide / adverse effects
-
Vidarabine / administration & dosage
-
Vidarabine / adverse effects
-
Vidarabine / analogs & derivatives*
Substances
-
Thalidomide
-
Cyclophosphamide
-
Vidarabine
-
fludarabine